Published in Recenti Prog Med on October 01, 2009
2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum (2013) 5.99
Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis. N Engl J Med (2006) 4.46
Management of minor head injury in patients receiving oral anticoagulant therapy: a prospective study of a 24-hour observation protocol. Ann Emerg Med (2012) 3.55
2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. Ann Rheum Dis (2013) 3.11
Imatinib for refractory chronic graft-versus-host disease with fibrotic features. Blood (2009) 2.51
Regional Implantation of Autologous Adipose Tissue-Derived Cells Induces a Prompt Healing of Long-Lasting Indolent Digital Ulcers in Patients With Systemic Sclerosis. Cell Transplant (2014) 2.02
Cyclophosphamide pulse regimen in the treatment of alveolitis in systemic sclerosis. J Rheumatol (2002) 1.97
Risk of non-Hodgkin lymphoma in celiac disease. JAMA (2002) 1.81
Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease. Blood (2007) 1.60
Microcirculatory effects of the transfusion of leukodepleted or non-leukodepleted red blood cells in patients with sepsis: a pilot study. Crit Care (2014) 1.56
Performance of the preliminary classification criteria for cryoglobulinaemic vasculitis and clinical manifestations in hepatitis C virus-unrelated cryoglobulinaemic vasculitis. Clin Exp Rheumatol (2012) 1.41
Role of viral infections in the etiopathogenesis of systemic sclerosis. Clin Exp Rheumatol (2013) 1.40
Traumatic peripheral nerve injuries: epidemiological findings, neuropathic pain and quality of life in 158 patients. J Peripher Nerv Syst (2010) 1.32
Bone marrow endothelial progenitors are defective in systemic sclerosis. Arthritis Rheum (2006) 1.30
Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients. Autoimmun Rev (2011) 1.26
Platelet-derived growth factor and reactive oxygen species (ROS) regulate Ras protein levels in primary human fibroblasts via ERK1/2. Amplification of ROS and Ras in systemic sclerosis fibroblasts. J Biol Chem (2005) 1.26
Long-term outcome and prospective validation of NIH response criteria in 39 patients receiving imatinib for steroid-refractory chronic GVHD. Blood (2013) 1.24
Reactive oxygen species are required for maintenance and differentiation of primary lung fibroblasts in idiopathic pulmonary fibrosis. PLoS One (2010) 1.15
Autoantibodies to fibroblasts induce a proadhesive and proinflammatory fibroblast phenotype in patients with systemic sclerosis. Arthritis Rheum (2002) 1.10
Systemic sclerosis (scleroderma) and cancer risk: systematic review and meta-analysis of observational studies. Rheumatology (Oxford) (2012) 1.06
Items for developing revised classification criteria in systemic sclerosis: Results of a consensus exercise. Arthritis Care Res (Hoboken) (2012) 1.06
Adverse drug events as a cause of hospitalization in older adults. Drug Saf (2012) 1.05
Subcutaneous immunoglobulin in polymyositis and dermatomyositis: a novel application. Autoimmun Rev (2010) 1.03
Sarcoidosis and cancer risk: systematic review and meta-analysis of observational studies. Chest (2015) 1.01
Incidence and characteristics of non-Hodgkin lymphomas in a multicenter case file of patients with hepatitis C virus-related symptomatic mixed cryoglobulinemias. Arch Intern Med (2005) 0.99
CNS demyelination during anti-tumor necrosis factor alpha therapy. J Neurol (2005) 0.97
Modified-release sildenafil reduces Raynaud's phenomenon attack frequency in limited cutaneous systemic sclerosis. Arthritis Rheum (2011) 0.90
Intravenous immunoglobulin as add on treatment with mycophenolate mofetil in severe myositis. Autoimmun Rev (2009) 0.88
Pathologic prion protein is specifically recognized in situ by a novel PrP conformational antibody. Neurobiol Dis (2006) 0.87
Low-dose oral imatinib in the treatment of systemic sclerosis interstitial lung disease unresponsive to cyclophosphamide: a phase II pilot study. Arthritis Res Ther (2014) 0.87
Efficacy and safety of peginterferon alfa-2b plus ribavirin for HCV-positive mixed cryoglobulinemia: a multicentre open-label study. Clin Exp Rheumatol (2011) 0.86
Open-label study on treatment with 20 % subcutaneous IgG administration in polymyositis and dermatomyositis. Clin Rheumatol (2014) 0.85
CCL2, CCL3 and CCL5 chemokines in systemic sclerosis: the correlation with SSc clinical features and the effect of prostaglandin E1 treatment. Clin Exp Rheumatol (2012) 0.84
Acute myocarditis associated with adenoviral infection in a patient with scleroderma. Clin Rheumatol (2003) 0.82
From scleredema to AL amyloidosis: disease progression or coincidence? Review of the literature. Clin Rheumatol (2005) 0.82
Familial hemifacial spasm and determinants of late onset. Neurol Sci (2009) 0.81
Ha-Ras stabilization mediates pro-fibrotic signals in dermal fibroblasts. Fibrogenesis Tissue Repair (2011) 0.80
Epstein-Barr virus antibodies mark systemic lupus erythematosus and scleroderma patients negative for anti-DNA. Immunology (2014) 0.80
Sudden onset of colitis after ablation of secretin-expressing lymphocytes in transgenic mice. Exp Biol Med (Maywood) (2004) 0.80
[Intravenous immunoglobulin treatment in autoimmune diseases]. Recenti Prog Med (2007) 0.79
Stiff and tight skin: a rear window into fibrosis without inflammation. Sci Transl Med (2010) 0.79
Role of the HLA class II: HCV-related disorders. Ann N Y Acad Sci (2007) 0.79
Characterization of the c-Myb-responsive region and regulation of the human type I collagen alpha 2 chain gene by c-Myb. J Biol Chem (2002) 0.78
Biologic Therapy in Inflammatory and Immunomediated Arthritis: Safety Profile. Curr Drug Saf (2016) 0.77
Detection of typical and atypical bovine spongiform encephalopathy and scrapie prion strains by prion protein motif-grafted antibodies. J Gen Virol (2009) 0.76
Biomechanical study of 16-mm threaded, 32-mm threaded, and fully threaded SCFE screw fixation. J Pediatr Orthop (2011) 0.76
Autoantibodies against the platelet-derived growth factor receptor in scleroderma: comment on the articles by Classen et al and Loizos et al. Arthritis Rheum (2009) 0.76
Myocardial perfusion defects in scleroderma detected by contrast-enhanced cardiovascular magnetic resonance. Radiol Med (2014) 0.76
Influence of age and autoimmunity on liver disease in HCV-associated type II mixed cryoglobulinemia. Hum Immunol (2002) 0.75
Reply to J. Magalon et al. Cell Transplant (2015) 0.75
Pemphigus vulgaris is characterized by low IgG reactivities to specific self-antigens along with high IgG reactivity to desmoglein 3. Immunology (2014) 0.75
Comment on 'Where are we going in the management of interstitial lung disease in patients with systemic sclerosis?'. Autoimmun Rev (2015) 0.75
Management of a pregnant woman with common variable immunodeficiency and previous reactions to intravenous IgG administration. BMJ Case Rep (2012) 0.75
Recurrent myelitis in common variable immunodeficiency successfully managed with high-dose subcutaneous immunoglobulin. BMJ Case Rep (2012) 0.75
Breast contouring in postbariatric patients: a technique selection algorithm. Obes Surg (2010) 0.75
Subcutaneous immunoglobulins in ocular myositis. Rheumatology (Oxford) (2012) 0.75
[The diagnostic admission in an internal medicine service: clinical and economic aspects]. Recenti Prog Med (2007) 0.75
Biologic Therapy in Inflammatory Immunomediated Systemic Diseases: Safety Profile. Curr Drug Saf (2016) 0.75
Further evidence of genetic heterogeneity in autosomal dominant distal motor neuronopathy. Neuromuscul Disord (2004) 0.75
Atopic myelitis is not restricted to Japanese patients. Neurol Sci (2014) 0.75
PYY-Tag transgenic mice displaying abnormal (H+-K+)ATPase activity and gastric mucosal barrier impairment. Lab Invest (2003) 0.75